We’ve joined the Health Research Authority, the National Institute for Health and Care Research, and a host of organisations ...

It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

All NICE products on vulnerable groups. Includes any guidance and quality standards.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

If you are interested in getting a health technology evaluated by NICE you should ensure that the product is registered with the NHS Innovation Service. That will ensure that it is considered in the ...

Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour Interventional procedure consultation Interventional procedures guidance 19 December 2024 Digital ...

For further information on the guideline development process, please see how we develop NICE guidelines ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1015 13 November 2024 13 November 2024 ...

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 12 February 2025 Abaloparatide for treating ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.